Medications Used in Detox: How Doctors Manage Withdrawal Safely

Medically reviewed by [REVIEWER NAME, CREDENTIALS] — [REVIEW DATE]

For many people, the scariest part of getting help isn't rehab — it's detox. If you've ever tried to quit drinking or using on your own, you already know how brutal withdrawal can feel. What most people don't know is what actually happens inside a medically supervised detox program: which medications doctors use, why they use them, and how those medicines turn a frightening, white-knuckle experience into a managed, monitored medical process.

This guide opens up the detox medicine cabinet. We'll walk through the medications clinicians use for alcohol, opioid, benzodiazepine, and stimulant withdrawal — the same evidence-based approach we use in the Detox Programs at Northern Illinois Recovery in Crystal Lake, Illinois, serving McHenry County, Chicagoland, and all of northern Illinois.

Medical safety disclaimer: Never stop alcohol, benzodiazepines, or opioids abruptly without medical supervision. Alcohol and benzodiazepine withdrawal can cause seizures and delirium tremens (DTs), which can be fatal. Opioid withdrawal, while rarely deadly on its own, dramatically raises overdose risk if a person relapses with lowered tolerance. If you or a loved one is dependent on any of these substances, talk to a medical professional before making any change.

---

Why Medication Support Matters in Withdrawal

Withdrawal happens because the brain and body have adapted to a substance's constant presence. Remove it suddenly, and the nervous system rebounds — sometimes violently. Medications in detox serve three core purposes:

1. Safety. Certain withdrawal syndromes — especially alcohol and benzodiazepines — carry real medical danger, including seizures, dangerous blood pressure spikes, and delirium tremens. The right medication protocol prevents most of these complications before they start.
2. Comfort. Untreated withdrawal symptoms (tremors, nausea, insomnia, anxiety, muscle and bone pain) are a leading reason people abandon detox and return to use. Reducing symptom severity helps people actually complete withdrawal.
3. A bridge to treatment. Detox alone is not treatment. SAMHSA's TIP 45: Detoxification and Substance Abuse Treatment — the federal consensus protocol on withdrawal management — is explicit that detox should be the entry point into a continuum of care, not a standalone event. Medications started in detox (like buprenorphine or naltrexone) often continue into residential treatment, PHP, IOP, or outpatient care.

That last point is where "medically supervised" earns its name: it's not just someone handing you pills. It's assessment, monitoring with validated scales, dose adjustments in real time, and a warm handoff into the next level of care.

Comfort Medications vs. Substitution Medications

Detox medications fall into two broad categories, and understanding the difference demystifies most of what happens in a detox unit:

• Substitution (agonist or cross-tolerant) medications act on the same receptors as the substance the body depends on, allowing clinicians to stabilize the patient and then taper down in a controlled way. Examples: buprenorphine or methadone for opioids; benzodiazepines like chlordiazepoxide or lorazepam for alcohol; a long-acting benzodiazepine taper for benzodiazepine dependence.
• Comfort (symptom-targeted) medications don't replace the substance — they treat specific withdrawal symptoms. Examples: clonidine or lofexidine for the adrenaline surge of opioid withdrawal; anti-nausea medication (ondansetron); antidiarrheals (loperamide); NSAIDs for muscle aches; hydroxyzine for anxiety; trazodone for sleep; thiamine and other vitamins during alcohol detox to prevent Wernicke's encephalopathy.

Most detox protocols combine both: a primary medication that controls the dangerous core of the withdrawal syndrome, plus comfort medications tailored to the individual.

Detox Medications by Substance

Substance	Primary medications	Supporting/comfort medications	Key clinical tool
Alcohol	Benzodiazepines (chlordiazepoxide, diazepam, lorazepam)	Thiamine, folate, fluids/electrolytes, anticonvulsant adjuncts in select cases	CIWA-Ar symptom-triggered dosing
Opioids	Buprenorphine or methadone (taper or maintenance)	Clonidine or lofexidine, anti-nausea/antidiarrheal meds, sleep aids, NSAIDs; naltrexone after full withdrawal	COWS (Clinical Opiate Withdrawal Scale)
Benzodiazepines	Gradual, structured taper — often after switching to a long-acting benzodiazepine	Adjunctive anticonvulsants or other supports in select cases	Slow, individualized taper schedule
Stimulants (cocaine, meth)	No FDA-approved withdrawal medication	Symptom-targeted: sleep support, anti-agitation medication, hydration, nutrition; monitoring for depression	Close psychiatric monitoring

Alcohol: Benzodiazepine Protocols, Guided by CIWA-Ar

Alcohol withdrawal is one of the two withdrawal syndromes that can kill. Benzodiazepines are the first-line treatment because they act on the same GABA receptors alcohol does, calming the overexcited nervous system and — critically — reducing the risk of withdrawal seizures and delirium tremens. This is the standard reflected in SAMHSA's TIP 45 and in the National Institute on Alcohol Abuse and Alcoholism's (NIAAA) clinical guidance on managing alcohol withdrawal.

In practice, nurses assess patients regularly using the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) — a 10-item scale measuring tremor, sweating, agitation, nausea, and other symptoms. In symptom-triggered protocols, medication doses are given based on the score, which means patients get exactly as much medication as their withdrawal requires — no more, no less. Clinicians also give thiamine (vitamin B1) and other nutritional support, because chronic heavy drinking depletes thiamine and can lead to Wernicke's encephalopathy, a serious neurological emergency.

Opioids: Buprenorphine, Methadone, Clonidine — and Naltrexone Afterward

Opioid withdrawal ("dope sickness") is rarely fatal by itself, but it's intensely miserable, and the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder (2020 Focused Update) is clear that methadone and buprenorphine are more effective than symptom-only approaches at relieving withdrawal, keeping patients in withdrawal management, and helping them complete it.

• Buprenorphine is a partial opioid agonist. Per FDA labeling for buprenorphine products (e.g., Suboxone), the first dose should be given only when clear, objective signs of withdrawal are present — starting it too early while a full opioid is still in the system can trigger precipitated withdrawal, a sudden and severe symptom flare. Once induced, buprenorphine relieves withdrawal and cravings and can be tapered or, more often, continued as ongoing treatment.
• Methadone is a full agonist used for stabilization and maintenance in federally regulated opioid treatment programs.
• Clonidine and lofexidine are alpha-2 adrenergic agonists that blunt the "adrenaline storm" of opioid withdrawal — sweating, anxiety, racing heart, gooseflesh. Lofexidine (Lucemyra) became the first FDA-approved non-opioid medication specifically for opioid withdrawal symptoms in 2018. These are useful when opioid agonists aren't appropriate, though ASAM notes they're less effective than buprenorphine or methadone.
• Naltrexone works differently: it's an opioid blocker, not a substitute. It can only be started after withdrawal is complete. The FDA label for extended-release naltrexone (Vivitrol) requires patients to be opioid-free — typically a minimum of 7–14 days, including off buprenorphine or methadone — before the first dose, or it will precipitate severe withdrawal. That's exactly why naltrexone induction belongs in a supervised setting where the timing can be managed safely.

Benzodiazepines: The Structured Taper

There is no "quick detox" from benzodiazepines — and abruptly stopping them is genuinely dangerous. In 2020, the FDA updated the boxed warning on the entire benzodiazepine class, cautioning that abrupt discontinuation or rapid dose reduction can trigger acute withdrawal reactions, including life-threatening seizures, and directing clinicians to use a gradual, patient-specific taper.

In a supervised detox, clinicians typically convert the patient to an equivalent dose of a long-acting benzodiazepine (such as diazepam or chlordiazepoxide), stabilize them, then reduce the dose on a gradual schedule — pausing or slowing the taper if symptoms flare. Depending on the dose and duration of use, a safe taper can take weeks. This is slower than most people expect, and that's the point: slow is safe.

Stimulants: Symptom-Targeted Support

There's currently no FDA-approved medication for cocaine or methamphetamine withdrawal. Stimulant withdrawal isn't typically medically dangerous the way alcohol or benzo withdrawal is, but the "crash" — profound fatigue, hypersomnia, intense cravings, and sometimes severe depression with suicidal thoughts — needs real clinical attention. Detox teams provide symptom-targeted medications for sleep, agitation, and mood, along with hydration, nutrition, and close psychiatric monitoring, then transition patients quickly into therapy-based treatment, where the evidence for stimulant use disorder is strongest.

How Medication Decisions Are Individualized

No two detoxes look alike. Before the first dose, the medical team assesses:

• What substances are involved — polysubstance use (for example, alcohol plus benzodiazepines, or opioids plus stimulants) changes the entire plan
• How much, how long, and how recently the person has been using
• Medical history — liver or kidney function, seizure history, heart conditions, pregnancy
• Mental health conditions — anxiety, depression, PTSD, and other diagnoses shape both comfort medications and the dual-diagnosis treatment plan that follows detox
• Prior withdrawal history — previous seizures or DTs predict a rougher course and call for more aggressive protection

Vital signs and validated scales (CIWA-Ar, COWS) are checked around the clock, and doses are adjusted to the person in the bed — not to a one-size-fits-all schedule. At Northern Illinois Recovery, this individualized approach continues past detox through our Medication Management program, where prescribers monitor and fine-tune psychiatric and recovery medications throughout treatment.

MAT After Detox: Medications Don't Stop at Discharge

Here's a truth SAMHSA's TIP 63: Medications for Opioid Use Disorder emphasizes: for opioid use disorder in particular, the medication is often the treatment — not just a detox tool. Buprenorphine, methadone, and naltrexone are the three FDA-approved medications for OUD, and continuing one of them after detox substantially reduces relapse and overdose risk compared with detox alone. Similarly, people completing alcohol detox may benefit from naltrexone or acamprosate to reduce cravings and support abstinence.

That's why detox at Northern Illinois Recovery isn't a dead end — it flows directly into Medication-Assisted Treatment alongside residential care, PHP, IOP, outpatient, and telehealth services. A patient can start buprenorphine on day one of detox and still be supported on it months later in outpatient treatment, with therapy and dual-diagnosis care wrapped around it the whole way.

Why Medically Supervised Detox — and the Dangers of Quitting Alone

Every medication described above has a flip side: used at the wrong time, in the wrong dose, or without monitoring, it can cause harm. That's the core reason self-medicating withdrawal is so dangerous:

• Alcohol and benzodiazepine withdrawal can be fatal. Seizures and delirium tremens can develop quickly, sometimes in people who've had "manageable" withdrawals before. There is no safe home protocol for significant alcohol or benzo dependence.
• Timing errors cause precipitated withdrawal. Taking buprenorphine too soon, or naltrexone before the body is fully opioid-free, can trigger sudden, severe withdrawal — a medical situation, not a comfort problem.
• Using leftover benzos or street medications to "self-taper" means unknown doses, unknown purity, and — in today's supply — real fentanyl contamination risk in counterfeit pills.
• Relapse after partial detox is peak overdose danger. Even a few days of abstinence lowers opioid tolerance; returning to a previous dose can be lethal.

Medically supervised Withdrawal Management exists to remove all of that guesswork. In our Crystal Lake detox unit, 24/7 nursing, physician-directed protocols, and per-substance detox tracks mean the medications above are given at the right time, in the right dose, with someone watching your vitals — and a full continuum of care waiting when withdrawal is over. If you're anywhere in McHenry County, the Chicago suburbs, Rockford, or Lake and Kane counties, help is close to home; see our Locations page or reach out directly.

Take the First Step — Safely

You don't have to understand every medication in this article to get help. You just have to make one call. Our admissions team can explain what your detox would look like, answer medication questions, and check your coverage in minutes — most major insurance plans are accepted.

Verify your insurance or start admissions with Northern Illinois Recovery today. Withdrawal managed by professionals isn't something to fear — it's the safest first step toward getting your life back.

---

Sources referenced in this article: SAMHSA, TIP 45: Detoxification and Substance Abuse Treatment; SAMHSA, TIP 63: Medications for Opioid Use Disorder; American Society of Addiction Medicine, The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update; FDA prescribing information for Suboxone (buprenorphine/naloxone) and Vivitrol (extended-release naltrexone); FDA Drug Safety Communication, Benzodiazepine Drug Class — Boxed Warning Updated to Improve Safe Use (2020); NIAAA clinical guidance on alcohol withdrawal management.

This article is for educational purposes and is not a substitute for medical advice. Treatment decisions, including all medication choices, should be made with a licensed medical provider.